Weizmann Institute

Yeda Technology Transfer

Ayelet Erez

Rare Genetic Defect May Lead to Cancer Drug

17.05.2017

Yeda Technology Transfer, Diagnostic Techniques and Drugs

A lack of the protein citrin slows children's growth; blocking it in cancer slows tumor growth

Dr. Valery Krizhanovsky

Getting Rid of Old Cells

17.05.2017

Personalized Medicine, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs

Understanding why cells refuse to die may lead to treatments for age-related disease

Dr. Daniela Novick

Staff Scientist: Dr. Daniela Novick

18.08.2016

Biochemistry, Immunology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs

A drug based on work done at the Weizmann Institute of Science saves the life of a girl

Varda Rotter and Moshe Oren

Reeducating Renegade p53

15.08.2016

Cancer, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs

Mutated proteins that abet cancer growth can be turned against the cancer

aqueous humor ion pump

Blocking Pumps in the Eye To Block Glaucoma

13.06.2016

Biochemistry, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs

A new compound targets just one version of an ion pump, avoiding side effects

Bruce Lefker and Berta Strulovici

Weizmann Institute of Science Announces Visiting Scientist Agreement with Pfizer Inc.

05.06.2016

Yeda Technology Transfer, Benefiting Humanity, Diagnostic Techniques and Drugs

The Weizmann Institute of Science in Rehovot, Israel, and Yeda Research and Development Co., Ltd., its commercial arm, announced this week that they...

YEDA

One Patent, Three Drugs

16.03.2016

Cancer, Immunology, Yeda Technology Transfer, Diagnostic Techniques and Drugs

Portrazza is approved to by the US FDA to treat lung cancer

Amir Naiberg, Prof. Mudi Sheves, Stefan Oschmann and Belén Garijo

Merck and Weizmann Institute Sign New Framework Agreement on Research Collaboration

16.02.2016

Yeda Technology Transfer, Biotechnology, Diagnostic Techniques and Drugs

Merck, a leading science and technology company, today extended the partnership with Weizmann Institute of Science, Rehovot, Israel, by signing a new...

cancer-free prostate

Weizmann Institute Drug, TOOKAD® Soluble, Approved for Prostate Cancer Therapy in Mexico

04.01.2016

Life Sciences, Biochemistry, Cancer, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Biotechnology, Diagnostic Techniques and Drugs

Canadian Institute for the Energies and Applied Research

Weizmann Institute Solar Technology to Convert Greenhouse Gas into Fuel

07.06.2012

Energy, Yeda Technology Transfer

An Australian company will develop the technology to reduce coal emissions

Pages

Top Stories

self-driving dashboard

The Human Test for Computer-Written Code

infrared silkworm

Microscopic Silk Cocoons May Facilitate Drug Design

Minerals in a Family of Asteroids Reveal Martian Roots

Prof. Itamar Procaccia

Prof. Itamar Procaccia

Press Releases

Microscopic Silk Cocoons May Facilitate Drug Design

Weizmann House Reopens to the Public

The Dust Storm Microbiome

Facebook

Twitter

Tweets by @WeizmannScience

.